Updates from SMR Meeting: ‘The Innovation Landscape’

SMR meeting

Back in July 2022 the SMR (Society for Medicines Research) hosted a conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’ That conference looked at ongoing developments in pharmaceutical discovery and development, focused on the need for partnerships between large pharmaceutical and new biotech companies to tackle the next generation therapeutic […]

First drug approval in NASH

NASH TherapeutAix

When we reviewed the R&D landscape in nonalcoholic steatohepatitis (NASH) in 2018, we highlighted 4 development programs that were in Phase 3 development and all targeting pivotal data readout, and a potential launch, between 2019 and 2021. However, obeticholic acid, elafibranor, cenicriviroc, and selonsertib all turned out to not confirm their initial positive data in […]

SMR meeting: The Innovation Landscape

SMR meeting

On Tuesday 26 March Darcey Black, Translational Science Director at TherapeutAix, will be co-organising and co-sharing the SMR meeting taking place at Friends House, London. This SMR meeting follows on from the 2022 conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’ and its goal is to better understand these evolutionary […]

Welcome 2024

With the New Year up and running, we all got together in Aachen for a Board Meeting.  In addition to mapping out activities for 2024, we focused on two additional areas. The first was a strategic review of our services and how these align with our client’s needs. While we’re receiving superb feedback in our […]

TherapeutAix Roundup: 2023

TherapeutAix Roundup: 2023

As 2023 comes to an end we wanted to take the time to reflect upon the year and share what we have been up to. From supporting our clients, participating in scientific meetings, and facilitating workshops to refreshing our website, it has been a busy year for the team at TherapeutAix. Our clients and their […]

SMR: Recent Clinical Candidates and SMR Award Meeting

SMR meeting

Darcey Black, Translational Science Director at TherapeutAix, will be attending the bi-annual SMR Meeting taking place at Friends House, London, on Monday 4th December. The meeting will include presentations highlighting recent clinical candidates across therapeutic areas including cancer, immune disease and more, with a variety of targeting modalities. The meeting will include the presentation of […]

TherapeutAix to attend ERS International Congress

TherapeutAix will be at the ERS International Congress 2023 taking place in Milan, Italy from 9-13 September. The Congress, hosted at MiCo, will bring together the world’s respiratory experts to showcase the latest advances in respiratory medicine and science. The theme of this year’s Congress is ‘Pollution, climate change and sustainable developments’ and will look at the […]

Join TherapeutAix at the SMR Meeting ‘Innovative New Pharma & Biotech Partnerships’

SMR Innovation

Darcey Black, Translational Director at TherapeutAix, will be co-organising and attending the ‘Innovative New Pharma and Biotech Partnerships: How is the landscape transforming?’ SMR Meeting taking place on 7th July 2022 at GSK Stevenage.   The meeting will feature a panel; of experts from industry, CROs, medical charities and VCs who will share experiences and lessons […]

International NASH Day 2022 – Enabling therapies for patients

International NASH Day 2022

Non-alcoholic steatohepatitis, or NASH, remains a disease with no approved therapeutics. And it’s been a tough area for drug development, with numerous Phase 2b and Phase 3 failures in the last few years. As a result, the landscape of active development projects has changed quite a bit from the time our review on NASH was […]

TherapeutAix to present at Extracellular Matrix Pharmacology Congress

TherapeutAix is attending and presenting at the Extracellular Matrix Pharmacology Congress 2022, on 23-25 June at the Tivoli Congress Centre in Copenhagen.  The congress will bring together experts from across the industry to discuss the extracellular matrix across organ diseases including liver, lung, kidney, skin, and immunology.  Darcey Black (Director, Translational) will be presenting a […]

We’d like to send you our company updates, invites to events and any other relevant news. By providing your details and subscribing to this list, you are giving us your consent to send you these updates.

We’ll always be mindful of how often we send our updates and you can amend your preferences at any time.

We’ll never sell or swap your data with any organisation and we’ll store your details securely, respecting your trust and privacy. Please view our privacy policy for further details.

Marketing Permissions
Please select all the ways you would like to hear from TherapeutAix:
You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.